India's dependence on pharma imports from China: Minister informs parliament Medical Dialogues Bureau17 March 2020 10:20 AM GMTDelhi: Through a written reply in the Lok Sabha Shri. D.V. Sadananda Gowda, Minister for Chemicals & fertilizers informed the parliament about the ...
Coronavirus Scare: Minister apprises parliament about the availability of drugs and shortages Medical Dialogues Bureau14 March 2020 9:33 AM GMTDelhi: Through a written reply in the Rajya Sabha Shri. D.V. Sadananda Gowda, Minister for Chemicals & fertilizers informed the parliament that eno...
Morepen Labs adds blockbuster Rivaroxaban, Vildagliptin, UDCA to API portfolio Farhat Nasim14 Oct 2019 8:06 AM GMTWhile two products Rivaroxaban and Vildagliptin will augment Morepen Lab's presence in the cardiac and diabetic segments respectively, the third produc...
Aurobindo Pharma Unit-7 documents inaccurate, misleading: USFDA Medical Dialogues Bureau11 Oct 2019 4:30 AM GMT'The responsibilities and procedures applicable to the quality control unit are not fully followed. Several lists of documents requested were either pr...
CDSCO commitee warns against repacking of Active Pharmaceutical Ingredients into smaller packs by Wholesalers Meghna A Singhania27 Sep 2019 6:49 AM GMTNew Delhi : Taking into consideration, the proposal on measures need to be taken to address the issue of repacking of Active Pharmaceutical...
Biocon inks license, supply pact with CMS for 3 generic formulations Medical Dialogues Bureau13 Sep 2019 9:15 AM GMTUnder the terms of the agreement, Biocon will be responsible for the development, manufacturing and supply of the products and China Medical System Hol...
Grant of Manufacturing License for Drugs: DTAB recommends amendment of Drugs and Cosmetics Rules, 1945 Medical Dialogues Bureau29 Aug 2019 10:40 AM GMTNew Delhi: The Drugs Technical Advisory Board (DTAB) has recently recommended for amendment of the Drugs and Cosmetics Rules, 1945 regarding...
CDSCO preparing list of dual-use APIs imported from unregistered firms Medical Dialogues Bureau26 Aug 2019 8:53 AM GMT'The Central Drugs Standard Control Organisation (CDSCO), the Ministry of Health and the Department of Pharmaceuticals want to put a stop to the misuse...
USFDA completes inspection at Laurus Labs' AP unit Medical Dialogues Bureau19 July 2019 4:32 AM GMTMumbai: Laurus labs recently announced that they have completed the US Food and Drug Administration (USFDA) inspection of Unit 4 at Visakhapatnam,...
Dr Reddys plans to launch value-added drugs in US as part of diversification, market entry strategy Medical Dialogues Bureau8 July 2019 8:02 AM GMTAs part of the diversification and new market entry strategy, DRL (Dr Reddys) plans to re-focus some of its Research and Development resources to servi...
Alchem solves stability dilemma for micronized DIGOXIN; files PATENT for novel production process Meghna A Singhania16 April 2019 11:17 AM GMTAlchem's molecule is the sole micronized digoxin available globally that resolves the challenge of micro dosage formulation and the long-term stability...
Over 75 percent of Indian drug import comes from China says pharma body IPCA Ruby Khatun Khatun21 Dec 2017 4:00 AM GMTNew Delhi: An overwhelming dependence on drug imports and related raw materials from China could prove harmful for the health sector in India in the...
